ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $109.2B | +30.0% | 3.6% | 7.7% |
| Total assets (Q2 2026) | $109.2B |
|---|---|
| YoY | +30.0% |
| 5-year CAGR | 3.6% |
| 10-year CAGR | 7.7% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $86.7B | +6.5% |
| 2024 | $81.4B | +11.2% |
| 2023 | $73.2B | −1.6% |
| 2022 | $74.4B | −1.0% |
| 2021 | $75.2B | +3.6% |
| 2020 | $72.5B | +6.9% |
| 2019 | $67.9B | +1.1% |
| 2018 | $67.2B | −11.9% |
| 2017 | $76.3B | +44.8% |
| 2016 | $52.7B | +27.7% |
| 2015 | $41.2B | +0.1% |
| 2014 | $41.2B | −4.1% |
| 2013 | $43.0B | −36.1% |
| 2012 | $67.2B | +11.5% |
| 2011 | $60.3B | −0.5% |
| 2010 | $60.6B | +15.2% |
| 2009 | $52.6B | +24.0% |
| 2008 | $42.4B | +6.8% |
| 2007 | $39.7B | — |